Medications for Cryptococcal Meningitis, Immunosuppressed Host
About Cryptococcal Meningitis, Immunosuppressed Host: Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord (meninges), caused by the fungus Cryptococcus neoformans. Cryptococcal meningitis most often affects people with a weakened immune system.
Drugs Used to Treat Cryptococcal Meningitis, Immunosuppressed Host
The following list of medications are in some way related to, or used in the treatment of this condition.
Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
fluconazole | C | N | Add review | Rate | |||
Generic name: fluconazole systemic Brand name: Diflucan Drug class: azole antifungals For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
amphotericin b | B | N | Add review | Rate | |||
Generic name: amphotericin b systemic Brand names: Amphocin, Fungizone Drug class: polyenes For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Diflucan | C | N | Add review | Rate | |||
Generic name: fluconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
flucytosine | C | N | Add review | Rate | |||
Generic name: flucytosine systemic Brand name: Ancobon Drug class: miscellaneous antifungals For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
AmBisome | B | N | Add review | Rate | |||
Generic name: amphotericin b liposomal systemic Drug class: polyenes For consumers: dosage, interactions, side effects |
|||||||
Amphocin | B | N | Add review | Rate | |||
Generic name: amphotericin b systemic Drug class: polyenes For consumers: dosage, interactions, side effects |
|||||||
Sporanox | C | N | Add review | Rate | |||
Generic name: itraconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Fungizone | B | N | Add review | Rate | |||
Generic name: amphotericin b systemic Drug class: polyenes For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
itraconazole | C | N | Add review | Rate | |||
Generic name: itraconazole systemic Brand names: Sporanox, Onmel, Sporanox PulsePak Drug class: azole antifungals For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Ancobon | C | N | Add review | Rate | |||
Generic name: flucytosine systemic Drug class: miscellaneous antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Onmel | C | N | Add review | Rate | |||
Generic name: itraconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Sporanox PulsePak | C | N | Add review | Rate | |||
Generic name: itraconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects |
|||||||
amphotericin b liposomal | B | N | Add review | Rate | |||
Generic name: amphotericin b liposomal systemic Brand name: AmBisome Drug class: polyenes For consumers: dosage, interactions, For professionals: A-Z Drug Facts |
|||||||
Learn more about Cryptococcal Meningitis, Immunosuppressed Host
Drugs.com Health Center
Legend
Off Label | This medication may not be approved by the FDA for the treatment of this condition. |
---|
Prescription Only / Over the Counter | |
---|---|
Rx | Prescription Only |
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Pregnancy | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act Schedule | |
---|---|
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |